Brian R. Jackson, MD

Associate Professor, University of Utah School of Medicine

Education

• Master’s Degree–Medical Informatics, University of Utah
• Medical Degree–University of Utah
• Residency–Medical Informatics, Dartmouth-Hitchcock Medical Center
• Fellowship—National Library of Medicine Informatics, University of Utah

Certification/Affiliations

• American Board of Pathology
• American Medical Informatics Association
• College of American Pathologists

Research Interests

• Economic analysis of diagnostic testing
• Physician utilization of laboratory tests
• Corporate social responsibility in healthcare

Recent Publications

• Whitehead NS, et al. The effect of laboratory test-based clinical decision support tools on medication errors and adverse drug events: a laboratory medicine best practices systematic review. J Appl Lab Med. 2019 May;3(6):1035–48.
• Jackson BR. Social responsibility practices of EHR vendors: an analysis of disclosures in annual corporate reports and websites. AMIA Annu Symp Proc. 2018;2018:609–15.
• Hueth KD, Jackson BR, Schmidt RL. An audit of repeat testing at an academic medical center: guideline adherence and potential cost savings. Am J Clin Pathol. 2018 May 31;150(1):27–33.
• Rudolf J,et al. Organizational benchmarks for test utilization performance: an example based on positivity rates for genetic tests. Am J Clin Pathol. 2017 Apr 1;147(4):382–9.
• Tebo AE, Haven TR, Jackson BR. Autoantibody diversity in paraneoplastic syndromes and related disorders: the need for a more guided screening approach. Clin Chim Acta. 2016 Aug 1; 459:162–9.
• Wilson AR, et al. Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study. BMC Womens Health. 2016;16(1):41.
• Signorelli H, et al.Benchmarking to identify practice variation in test ordering: a potential tool for utilization management. Lab Med. 2015 Fall:46(4):356–64.
• Walker BS, et al. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat Diagn. 2015 May;35(5):440–6.
• Hauser RG, Jackson BR, Shirts BH. A bayesian approach to laboratory utilization management. J Pathol Inform, 2015;6(1):10.
• Walker BS, et al. A Cost-effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States. PLoS ONE. 2015;10(7):e0131402.
• Schmidt RL, et al. An analysis of clinical consultation activities in clinical chemistry: implications for transformation and resident training in chemical pathology. Arch Pathol Lab Med. 2014 May:138(5):671–7.
• Hickner J, et al. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med. 2014 Mar-Apr;27(2):268–74.
• Wilson AR, et al. Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact. Online J Public Health Inform. 2014 Dec 15:6(3):e194.